Organoids in modelling infectious diseases.
Drug Discov Today
; 27(1): 223-233, 2022 01.
Article
en En
| MEDLINE
| ID: mdl-34418577
Approaches based on animal and two-dimensional (2D) cell culture models cannot ensure reliable results in modeling novel pathogens or in drug testing in the short term; therefore, there is rising interest in platforms such as organoids. To develop a toolbox that can be used successfully to overcome current issues in modeling various infections, it is essential to provide a framework of recent achievements in applying organoids. Organoids have been used to study viruses, bacteria, and protists that cause, for example, respiratory, gastrointestinal, and liver diseases. Their future as models of infection will be associated with improvements in system complexity, including abilities to model tissue structure, a dynamic microenvironment, and coinfection. Teaser. Organoids are a flexible tool for modelling viral, bacterial and protist infections. They can provide fast and reliable information on the biology of pathogens and in drug screening, and thus have become essential in combatting emerging infectious diseases.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Organoides
/
Evaluación Preclínica de Medicamentos
/
Infecciones
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Drug Discov Today
Año:
2022
Tipo del documento:
Article